CompletedPhase 3NCT00682578

A Comparative Study of Artekin With Standard Malarial Treatment Regimes in Afghanistan

Studying Malaria

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University of Oxford
Principal Investigator
Ghulam R Awab, MD
Provincial Malaria Control Centers (MRC)
Intervention
Dihydroartemisinin + Piperaquine (Artekin)(drug)
Enrollment
1086 target
Eligibility
All sexes
Timeline
2007 – 2010

Study locations (4)

Collaborators

Wellcome Trust · Ministry of public Health Afghanistan

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00682578 on ClinicalTrials.gov

Other trials for Malaria

Additional recruiting or active studies for the same condition.

See all trials for Malaria →

← Back to all trials